Schedule 13G ownership disclosure
Janux Therapeutics Inc
Common Stock · CUSIP: 47103J105
Event date: 2025-06-30
- Filing-level shares
- 3,345,664
- Percent of class
- 5.7%
- BlackRock, Inc.
Shares: 3,345,664 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-003076
- Form type
- SCHEDULE 13G
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Jul 17, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership